HLN - Haleon plc - Stock Price & Dividends

Haleon plc is a leading consumer healthcare company that develops, manufactures, and sells a wide range of products to promote health and wellness. With a presence in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific, the company caters to diverse consumer needs across the globe.

The company's oral health portfolio includes popular brands such as Sensodyne, Polident, Parodontax, and Biotene, offering toothpastes, mouthwashes, and denture care products that help people maintain good oral hygiene and prevent oral health issues. Additionally, Haleon provides vitamins, minerals, and supplements under the Centrum, Emergen-C, and Caltrate brands, supporting overall health and nutrition.

Haleon's over-the-counter (OTC) products address various health concerns, including respiratory issues, pain relief, and digestive health. The company's Otrivine, Theraflu, and Flonase brands offer nasal drops and cold, flu, and allergy relief products, while Voltaren, Panadol, and Advil brands provide anti-inflammatory and pain relief solutions. For digestive health, Haleon offers antacids and antihistamine products under the TUMS, ENO, and Fenistil brands.

With a rich history dating back to 1715, Haleon plc was formerly known as DRVW 2022 plc before adopting its current name in February 2022. Headquartered in Weybridge, the United Kingdom, the company continues to innovate and expand its product portfolio to meet the evolving needs of consumers worldwide. For more information, visit https://www.haleon.com.